Unlike commercial diet centers or app-based programs, our Chandler clinic provides in-person evaluations, lab-guided treatment adjustments, and consistent follow-up care
Efficacy and safety of GLP-1 agonists on metabolic parameters in non-diabetic patients with inflammatory bowel disease
Clinical trials show a similar incidence of gallstone-related events for both drugs (around 2.5% for semaglutide and 2.3% for tirzepatide)
Primarily, they act on the hypothalamus to enhance satiety, delay gastric emptying, and reduce caloric intake, leading to a preferential reduction in fat body mass (FBM)
Due to the requirement for in-person lab tests, physical exams, and ongoing glucose management, Klinic does not prescribe Ozempic since these steps are necessary for effective diabetes care, which cannot be managed solely through telehealth